A Randomized Controlled Study on the Clinical Efficacy of Ginkgo Biloba Combined with Nicorandil in Patients with HFmrEF
International Heart Journal · 31.01.2025 · 66 (1) · 74-80
DOI: 10.1536/ihj.24-316 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Heart Journal, erschienen am 31.01.2025. Verfasst von Xiang Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geratology, Weifang People's Hospital Affiliated with Shandong Second Medical University. Hauptthemen laut MEDLINE: Ginkgo biloba, Nicorandil, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geratology, Weifang People's Hospital Affiliated with Shandong Second Medical University.
Zitieren
APA
Gao, X., Liu, F., Han, X., Tang, S., Shen, D., Zhang, J., & Liu, C. (2025). A Randomized Controlled Study on the Clinical Efficacy of Ginkgo Biloba Combined with Nicorandil in Patients with HFmrEF. International Heart Journal, 66(1), 74-80. https://doi.org/10.1536/ihj.24-316
Vancouver
Gao X, Liu F, Han X, Tang S, Shen D, Zhang J, et al. A Randomized Controlled Study on the Clinical Efficacy of Ginkgo Biloba Combined with Nicorandil in Patients with HFmrEF. International Heart Journal. 2025;66(1):74-80. doi:10.1536/ihj.24-316
BibTeX
@article{Gao2025,
author = {Gao, Xiang and Liu, Fangyuan and Han, Xiaozhen and Tang, Shan and Shen, Dingding and Zhang, Jia and Liu, Chuanliang},
title = {A Randomized Controlled Study on the Clinical Efficacy of Ginkgo Biloba Combined with Nicorandil in Patients with HFmrEF},
journal = {International Heart Journal},
year = {2025},
volume = {66},
number = {1},
pages = {74--80},
doi = {10.1536/ihj.24-316}
}
EUVIMED